Emcure Pharmaceuticals Limited (NSE:EMCURE)

India · Delayed Price · Currency is INR

1,567.80

+46.70 (3.07%)

Mar 10, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011	Mar '10 Mar 31, 2010
Pharmaceuticals	78.96B	66.58B	59.86B	58.55B	50.33B
Pharmaceuticals Growth	18.59%	11.23%	2.23%	16.33%	-0.30%
Total	78.96B	66.58B	59.86B	58.55B	50.33B
Total Growth	18.59%	11.23%	2.23%	16.33%	-0.30%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2012	FY 2011	FY 2010
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011	Mar '10 Mar 31, 2010
India	36.59B	32.15B	31.82B	32.05B	25.10B
India Growth	13.82%	1.04%	-0.71%	27.67%	9.53%
ROW	14.15B	10.92B	8.87B	10.74B	11.29B
ROW Growth	29.55%	23.06%	-17.42%	-4.85%	97.64%
Europe	15.25B	14.24B	11.87B	8.97B	7.38B
Europe Growth	7.16%	19.90%	32.39%	21.47%	21.65%
North America	12.97B	9.28B	7.29B	6.79B	6.56B
North America Growth	39.75%	27.21%	7.35%	3.60%	-58.45%
Total	78.96B	66.58B	59.86B	58.55B	50.33B
Total Growth	18.59%	11.23%	2.23%	16.33%	-0.30%

Source: S&P Global Market Intelligence.